Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Pneumococcal Vaccine Candidate Targeting 25 Serotypes Advances

(MedPage Today) -- WASHINGTON -- A pneumococcal conjugate vaccine (PCV) covering 25 serotypes was safe and generated immune responses among infants that were comparable to the current 20-valent vaccine (Prevnar 20), a phase II trial showed....

Pneumococcal Vaccine Candidate Targeting 25 Serotypes Advances

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Tuesday 27 October →